Metabolic Syndrome and Fatal Outcomes in the Post-Stroke Event: A 5-Year Cohort Study in Cameroon

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Balti, Eric Vounsia ^a,b   Kengne, André Pascal ^b,c   Fokouo, Jean Valentin Fogha ^b   Nouthé, Brice Enid ^b,d   Sobngwi, Eugene ^b,e  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d MCGILL UNIVERSITY   (Canada)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAMEROON; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FATALITY; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEGRO; OUTCOME ASSESSMENT; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; URBAN AREA;

AGED; CAMEROON; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 84875676128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060117     Document Type: Article

References (26)

1. Grundy SM, (2012) Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 59: 635-643.
2. Wannamethee SG, Shaper AG, Lennon L, Morris RW, (2005) Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650.
3. Arnlov J, Ingelsson E, Sundstrom J, Lind L, (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121: 230-236.
4. Gupta AK, Dahlof B, Sever PS, Poulter NR, (2010) Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Diabetes Care 33: 1647-1651.
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
6. Gaillard T, Schuster D, Osei K, (2009) Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria. Ethn Dis 19: S2-S7.
7. Kengne AP, Anderson CS, (2006) The neglected burden of stroke in sub-Saharan Africa. Int J Stroke 1: 180-190.
8. Kengne AP, Ntyintyane LM, Mayosi BM, (2012) A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr 23: 103-112.
9. Kolo PM, Jibrin YB, Sanya EO, Alkali M, Peter Kio IB, et al. (2012) Hypertension-Related Admissions and Outcome in a Tertiary Hospital in Northeast Nigeria. Int J Hypertens 2012: 960546.
10. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123.
11. Sobngwi E, Kengne AP, Balti EV, Fezeu L, Nouthe B, et al. (2012) Metabolic profile of sub-Saharan african patients presenting with first-ever-in-lifetime stroke: association with Insulin Resistance. J Stroke Cerebrovasc Dis 21: 639-646.
12. Connor MD, Thorogood M, Modi G, Warlow CP, (2007) The burden of stroke in Sub-Saharan Africa. Am J Prev Med 33: 172-173.
13. Setel PW, Sankoh O, Rao C, Velkoff VA, Mathers C, et al. (2005) Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ 83: 611-617.
14. Warnick GR, Knopp RH, Fitzpatrick V, Branson L, (1990) Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 36: 15-19.
15. Okafor CI, (2012) The metabolic syndrome in Africa: Current trends. Indian J Endocrinol Metab 16: 56-66.
16. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya JC, (2007) Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 193: 70-76.
17. Motala AA, Mbanya JC, Ramaiya KL, (2009) Metabolic syndrome in sub-Saharan Africa. Ethn Dis 19: S2-10.
18. Tillin T, Forouhi NG, McKeigue PM, Chaturvedi N, (2006) The role of diabetes and components of the metabolic syndrome in stroke and coronary heart disease mortality in U.K. white and African-Caribbean populations. Diabetes Care 29: 2127-2129.
19. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
20. Galassi A, Reynolds K, He J, (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119: 812-819.
21. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110: 1251-1257.
22. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR, (2005) Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149: 33-45.
23. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, et al. (2004) Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27: 2689-2694.
24. Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, et al. (2011) Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol 68: 1245-1251.
25. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, et al. (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164: 1066-1076.
26. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.